Duodenal infusion of donor feces for recurrent Clostridium difficile
- PMID: 23323867
- DOI: 10.1056/NEJMoa1205037
Duodenal infusion of donor feces for recurrent Clostridium difficile
Abstract
Background: Recurrent Clostridium difficile infection is difficult to treat, and failure rates for antibiotic therapy are high. We studied the effect of duodenal infusion of donor feces in patients with recurrent C. difficile infection.
Methods: We randomly assigned patients to receive one of three therapies: an initial vancomycin regimen (500 mg orally four times per day for 4 days), followed by bowel lavage and subsequent infusion of a solution of donor feces through a nasoduodenal tube; a standard vancomycin regimen (500 mg orally four times per day for 14 days); or a standard vancomycin regimen with bowel lavage. The primary end point was the resolution of diarrhea associated with C. difficile infection without relapse after 10 weeks.
Results: The study was stopped after an interim analysis. Of 16 patients in the infusion group, 13 (81%) had resolution of C. difficile-associated diarrhea after the first infusion. The 3 remaining patients received a second infusion with feces from a different donor, with resolution in 2 patients. Resolution of C. difficile infection occurred in 4 of 13 patients (31%) receiving vancomycin alone and in 3 of 13 patients (23%) receiving vancomycin with bowel lavage (P<0.001 for both comparisons with the infusion group). No significant differences in adverse events among the three study groups were observed except for mild diarrhea and abdominal cramping in the infusion group on the infusion day. After donor-feces infusion, patients showed increased fecal bacterial diversity, similar to that in healthy donors, with an increase in Bacteroidetes species and clostridium clusters IV and XIVa and a decrease in Proteobacteria species.
Conclusions: The infusion of donor feces was significantly more effective for the treatment of recurrent C. difficile infection than the use of vancomycin. (Funded by the Netherlands Organization for Health Research and Development and the Netherlands Organization for Scientific Research; Netherlands Trial Register number, NTR1177.).
Comment in
-
Fecal microbiota transplantation--an old therapy comes of age.N Engl J Med. 2013 Jan 31;368(5):474-5. doi: 10.1056/NEJMe1214816. Epub 2013 Jan 16. N Engl J Med. 2013. PMID: 23323865 No abstract available.
-
Clostridium difficile infection: Real or fake--faecal matter does the trick for recurrent CDI.Nat Rev Gastroenterol Hepatol. 2013 Mar;10(3):129. doi: 10.1038/nrgastro.2013.16. Epub 2013 Jan 29. Nat Rev Gastroenterol Hepatol. 2013. PMID: 23358398 No abstract available.
-
[Infusion of donor feces in recurrent Clostridium difficile infection? - Infusion of donor feces: Promising intervention with several question marks].Dtsch Med Wochenschr. 2013 Mar;138(12):566. doi: 10.1055/s-0032-1329040. Epub 2013 Mar 12. Dtsch Med Wochenschr. 2013. PMID: 23483414 German. No abstract available.
-
Duodenal infusion of stool is more effective than vancomycin in patients with recurrent Clostridium difficile.Evid Based Med. 2013 Dec;18(6):220-1. doi: 10.1136/eb-2013-101308. Epub 2013 Apr 24. Evid Based Med. 2013. PMID: 23616152 No abstract available.
-
Duodenal infusion of feces for recurrent Clostridium difficile.N Engl J Med. 2013 May 30;368(22):2145. doi: 10.1056/NEJMc1303919. N Engl J Med. 2013. PMID: 23718168 No abstract available.
-
Duodenal infusion of feces for recurrent Clostridium difficile.N Engl J Med. 2013 May 30;368(22):2143. doi: 10.1056/NEJMc1303919. N Engl J Med. 2013. PMID: 23718169 No abstract available.
-
Duodenal infusion of feces for recurrent Clostridium difficile.N Engl J Med. 2013 May 30;368(22):2143-4. doi: 10.1056/NEJMc1303919. N Engl J Med. 2013. PMID: 23718170 No abstract available.
-
Duodenal infusion of feces for recurrent Clostridium difficile.N Engl J Med. 2013 May 30;368(22):2144. doi: 10.1056/NEJMc1303919. N Engl J Med. 2013. PMID: 23718171 No abstract available.
-
Duodenal infusion of feces for recurrent Clostridium difficile.N Engl J Med. 2013 May 30;368(22):2144. doi: 10.1056/NEJMc1303919. N Engl J Med. 2013. PMID: 23718172 No abstract available.
-
Infusión duodenal de heces de donante para recurrencia de Clostridium difficile.Rev Clin Esp (Barc). 2013 May;213(4):213. doi: 10.1016/j.rce.2013.02.005. Rev Clin Esp (Barc). 2013. PMID: 23814791 Spanish. No abstract available.
-
Fecal transplantation: beyond the aesthetic.Gastroenterology. 2013 Nov;145(5):1151-3. doi: 10.1053/j.gastro.2013.09.015. Epub 2013 Sep 19. Gastroenterology. 2013. PMID: 24055638 No abstract available.
-
Reply: To PMID 23323867.Gastroenterology. 2013 Nov;145(5):1153. doi: 10.1053/j.gastro.2013.09.016. Epub 2013 Sep 19. Gastroenterology. 2013. PMID: 24055639 No abstract available.
-
[Stool transplantation for relapsing Cl. difficile colitis].Z Gastroenterol. 2013 Dec;51(12):1441-3. doi: 10.1055/s-0033-1350583. Epub 2013 Dec 11. Z Gastroenterol. 2013. PMID: 24338758 German. No abstract available.
Similar articles
-
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection.Aliment Pharmacol Ther. 2015 May;41(9):835-43. doi: 10.1111/apt.13144. Epub 2015 Mar 1. Aliment Pharmacol Ther. 2015. PMID: 25728808 Clinical Trial.
-
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.Clin Infect Dis. 2017 Feb 1;64(3):265-271. doi: 10.1093/cid/ciw731. Epub 2016 Nov 9. Clin Infect Dis. 2017. PMID: 28011612 Clinical Trial.
-
[Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces].Ned Tijdschr Geneeskd. 2008 Aug 30;152(35):1927-32. Ned Tijdschr Geneeskd. 2008. PMID: 18808083 Dutch.
-
Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.Cochrane Database Syst Rev. 2005 Jan 25;(1):CD004610. doi: 10.1002/14651858.CD004610.pub2. Cochrane Database Syst Rev. 2005. Update in: Cochrane Database Syst Rev. 2007 Jul 18;(3):CD004610. doi: 10.1002/14651858.CD004610.pub3. PMID: 15674956 Updated. Review.
-
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.J Clin Gastroenterol. 2014 Sep;48(8):693-702. doi: 10.1097/MCG.0000000000000046. J Clin Gastroenterol. 2014. PMID: 24440934 Review.
Cited by
-
Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories.Clin Microbiol Rev. 2013 Jul;26(3):604-30. doi: 10.1128/CMR.00016-13. Clin Microbiol Rev. 2013. PMID: 23824374 Free PMC article. Review.
-
Net release and uptake of xenometabolites across intestinal, hepatic, muscle, and renal tissue beds in healthy conscious pigs.Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1;319(2):G133-G141. doi: 10.1152/ajpgi.00153.2020. Epub 2020 Jun 15. Am J Physiol Gastrointest Liver Physiol. 2020. PMID: 32538141 Free PMC article.
-
Challenges and costs of donor screening for fecal microbiota transplantations.PLoS One. 2022 Oct 20;17(10):e0276323. doi: 10.1371/journal.pone.0276323. eCollection 2022. PLoS One. 2022. PMID: 36264933 Free PMC article.
-
The gut microbiome in cardio-metabolic health.Genome Med. 2015 Mar 31;7(1):33. doi: 10.1186/s13073-015-0157-z. eCollection 2015. Genome Med. 2015. PMID: 25825594 Free PMC article. Review.
-
A human gut ecosystem protects against C. difficile disease by targeting TcdA.J Gastroenterol. 2017 Apr;52(4):452-465. doi: 10.1007/s00535-016-1232-y. Epub 2016 Jun 21. J Gastroenterol. 2017. PMID: 27329502 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical